Free Trial

Oxford Biomedica (LON:OXB) Stock Crosses Below 200 Day Moving Average - Here's What Happened

Oxford Biomedica logo with Medical background
Remove Ads

Oxford Biomedica plc (LON:OXB - Get Free Report) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 389.35 ($5.04) and traded as low as GBX 285 ($3.69). Oxford Biomedica shares last traded at GBX 286 ($3.70), with a volume of 189,113 shares trading hands.

Oxford Biomedica Trading Down 2.6 %

The company has a current ratio of 2.35, a quick ratio of 1.67 and a debt-to-equity ratio of 166.48. The firm has a market capitalization of £296.05 million, a P/E ratio of -2.07 and a beta of 1.09. The business has a 50 day moving average of GBX 384.97 and a 200-day moving average of GBX 389.35.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica LSE: OXB is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

Featured Stories

Should You Invest $1,000 in Oxford Biomedica Right Now?

Before you consider Oxford Biomedica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Biomedica wasn't on the list.

While Oxford Biomedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads